Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for Registrational ...
3h
Solid Biosciences Highlights FDA Path for SGT-003 DMD Study, Shares Early Friedreich’s Ataxia Update
Solid Biosciences (NASDAQ:SLDB) used a presentation at the 2026 Emerging Outlook Biotech Summit to outline its gene therapy-focused pipeline and discuss recent regulatory interactions around its lead ...
We’ve built a straightforward way to access a practical and effective alternative to suffering in silence.” — Karen Brunet, founder of Cntrl+ OTTAWA, ONTARIO, CANADA, February 4, 2026 ...
Drug tests are available for opioids, methamphetamine, cocaine, marijuana, barbiturates, phencyclidine, ...
Longevity Fund-backed Loyal is working toward FDA approval of a drug that could help dogs live longer, healthier lives. A canine health startup called Loyal has now raised more than $250 million to ...
Rockville’s RegenxBio just got a rejection from regulators on a treatment for a rare disease that it'd hoped would become its first product to market.
Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to ...
Balancing an important part of the immune system to resolve autoimmune diseases won a Nobel Prize last year. Now Nektar ...
A small SA software company is showing why Africa doesn’t need charity – it just needs to build systems that work, writes JP ...
Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for ...
ELIN PELIN, BG - February 09, 2026 - PRESSADVANTAGE - Algo Trading Space, an algorithmic trading education platform, ...
A Las Vegas-based biotech CEO has a vision of Nevada as a hub for medical innovation, and he is hoping voters will help him ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results